ELV - NYSE

Elevance Health Inc.

ELV·NYSE

$391.27

-2.8%

HealthcareMedical - Healthcare Plans

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$84.97B

EPS25.1800

P/E Ratio15.54

Earnings Date07/16/2026

121.49B

Assets

3Y+18.0%

5Y+40.0%

10Y+87.0%

77.47B

Total Liabilities

3Y+17.0%

5Y+45.0%

10Y+94.0%

44.03B

Total Equity

3Y+21.0%

5Y+33.0%

10Y+75.0%

Elevance Health Inc. Funding & Solvency Profile

ELV · NYSE

Current Assets

Cash & Cash Equivalents9.49B

Net Receivables15.23B

Inventory0.00

Other Current Assets0.00

Total Current Assets25 B

Non-Current Assets

Property, Plant & Equipment5.13B

Goodwill & Intangible Assets39.54B

Long-Term Investments38.58B

Other Non-Current Assets13.21B

Total Non-Current Assets57 B

Total Assets

121.49B

Financial Health Analysis

Current Ratio

1.24x

Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.

Debt-to-Equity Ratio

1.76x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

5 B

Positive working capital, but relatively tight. The company should monitor cash flow carefully.

Asset Composition

20% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Elevance Health Inc. Balance Sheet

ELV • NYSE

Elevance Health Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	9.5B	8.3B	6.5B	7.4B	4.9B	5.7B	4.9B	3.9B	3.6B	4.1B	2.1B	2.2B	1.6B	2.5B	2.2B	1.8B	4.8B	2.2B	2.8B	2.6B
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	23.4B	19.7B	16.7B	17.4B	17.2B	16.9B	17.5B	17.1B	16.9B	15.9B	17.3B	16.7B	0.0	3.7B	2.4B
Cash & Short-Term Investments	9.5B	8.3B	6.5B	7.4B	4.9B	29.2B	24.6B	20.6B	21B	21.3B	19.1B	19.6B	18.6B	19.4B	18.1B	19.1B	21.6B	2.2B	6.5B	5.1B
Net Receivables	15.2B	13.1B	12.5B	11.7B	9.7B	11B	10.4B	9.3B	8.8B	8.4B	7B	6.9B	5B	4.8B	4.3B	3.9B	4.2B	4.4B	3.9B	4.4B
Accounts Receivables	15.2B	13.1B	12.5B	11.7B	9.7B	5.3B	5B	6.7B	6.2B	5.9B	4.6B	4.8B	4B	3.7B	3.4B	3B	3.3B	3B	2.9B	2.3B
Other Receivables	0.0	0.0	0.0	0.0	0.0	5.7B	5.4B	2.6B	2.3B	2.5B	2.4B	2.1B	1.1B	927.6M	943.9M	878.6M	879.5M	1.4B	996.4M	2.1B
Other Current Assets	0.0	0.0	0.0	0.0	0.0	-40.1B	0.0	0.0	0.0	168.7M	316.6M	308.9M	235.7M	0.0	105.8M	32.3M	0.0	159.9M	0.0	0.0
Total Current Assets	24.7B	21.3B	19B	19.1B	14.6B	0.0	35B	30B	29.8B	29.8B	26.4B	26.9B	23.9B	24.2B	22.6B	23.1B	25.7B	6.8B	10.4B	9.5B
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	5.1B	5.2B	4.9B	4.9B	4.5B	3.5B	3.7B	2.7B	2.2B	2B	2B	1.9B	1.8B	1.7B	1.4B	1.2B	1.1B	1.1B	995.9M	988.6M
Goodwill	28.3B	28.3B	25.3B	24.4B	24.2B	21.7B	20.5B	20.5B	19.2B	17.6B	17.6B	17.1B	16.9B	16.9B	13.9B	13.3B	13.3B	0.0	13.4B	13.4B
Intangible Assets	11.2B	12.1B	10.3B	10.3B	10.6B	9.4B	8.7B	9B	8.4B	8B	8.2B	8B	8.4B	8.7B	7.9B	8B	8.3B	22.3B	9.2B	9.4B
Goodwill & Intangible Assets	39.5B	40.4B	35.6B	34.7B	34.8B	31.1B	29.2B	29.5B	27.6B	25.5B	25.7B	25B	25.4B	25.6B	21.8B	21.3B	21.5B	22.3B	22.7B	22.8B
Long-Term Investments	38.6B	37.2B	36.8B	33.3B	34B	25.6B	21.2B	18.7B	21.6B	19.2B	19B	19.9B	19.3B	18.6B	17.4B	17.6B	17B	14.5B	17.7B	2.4B
Tax Assets	298M	206M	228M	137M	103M	0.0	0.0	0.0	0.0	0.0	0.0	280.4M	383M	236.4M	424.8M	460.9M	523.8M	779M	559.6M	0.0
Other Non-Current Assets	13.2B	12.6B	12.4B	10.5B	9.4B	-60.1B	-11.6B	8.4B	10B	1.9B	-11.4B	6.5B	1.7B	7.4B	-12.1B	-14B	-13.7B	3.8B	-202M	15.9B
Total Non-Current Assets	96.8B	95.5B	89.9B	83.6B	82.9B	0.0	42.4B	41.6B	40.7B	35.3B	35.3B	34.8B	35.7B	34.7B	29.6B	27.1B	26.4B	41.6B	41.7B	42.1B
Other Assets	0.0	0.0	0.0	0.0	0.0	86.6B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Assets	121.5B	116.9B	108.9B	102.8B	97.5B	86.6B	77.5B	71.6B	70.5B	65.1B	61.7B	61.7B	59.6B	59B	52.2B	50.2B	52.1B	48.4B	52.1B	51.6B
LIABILITIES
CURRENT LIABILITIES
Total Payables	17.1B	15.7B	16.1B	15.6B	13.5B	16.9B	13B	12.4B	13B	11.9B	10.9B	10.5B	9.6B	9.3B	8.6B	2.9B	3B	2.9B	2.9B	2.7B
Accounts Payable	17.1B	15.7B	16.1B	15.6B	13.5B	16.9B	13B	12.4B	13B	11.9B	10.9B	10.5B	9.6B	9.3B	8.6B	2.9B	3B	2.9B	2.9B	2.7B
Short Term Debt	1.4B	2.2B	2B	1.9B	2B	700M	2.3B	2B	2.6B	1.4B	540M	1B	918M	807.1M	1.4B	805.9M	60.8M	1B	20.4M	521M
Tax Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2B	0.0	0.0	538.2M
Deferred Revenue	1.5B	1.5B	1.4B	1.1B	0.0	1.3B	1B	902M	860M	971.9M	1.1B	1.1B	822.7M	896.8M	926.5M	891.4M	1.1B	0.0	0.0	0.0
Other Current Liabilities	0.0	0.0	0.0	0.0	0.0	-18.8B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Current Liabilities	20B	19.4B	19.6B	18.7B	15.5B	29.5B	16.4B	15.3B	16.4B	14.2B	12.6B	12.6B	11.3B	11B	10.9B	4.6B	4.1B	3.9B	2.9B	3.2B
NON-CURRENT LIABILITIES
Long Term Debt	31.3B	29.9B	23.9B	23.1B	22B	19.3B	17.8B	17.2B	17.4B	14.4B	15.3B	14B	13.6B	14.2B	8.5B	8.1B	8.3B	7.8B	9B	6.5B
Deferred Revenue (Non-Current)	0.0	0.0	0.0	1.1B	1.2B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	2.1B	2.1B	2B	2B	2.8B	2B	2.2B	2B	1.7B	2.8B	2.6B	2.9B	3.3B	3.2B	2.7B	2.6B	2.5B	2.1B	3B	3.4B
Other Non-Current Liabilities	23.5B	23.4B	23.4B	20.8B	19B	-21.4B	9.4B	8.5B	8.5B	8.6B	8.1B	7.8B	6.6B	6.8B	6.8B	11B	12.3B	13.2B	14.1B	13.9B
Total Non-Current Liabilities	57.5B	56B	50B	47.8B	45.8B	0.0	29.4B	27.7B	27.6B	25.7B	26.1B	24.8B	23.5B	24.2B	18B	21.7B	23.2B	23.1B	26.1B	23.8B
Other Liabilities	0.0	0.0	0.0	0.0	0.0	53.4B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Capital Lease Obligations	529M	658M	685M	751M	864M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	77.5B	75.5B	69.5B	66.4B	61.3B	53.4B	45.7B	43B	44B	40B	38.7B	37.4B	34.8B	35.2B	28.9B	26.4B	27.3B	27B	29.1B	27B
SHAREHOLDERS' EQUITY
Common Stock	2M	2M	2M	2M	2M	3M	3M	3M	3M	2.6M	2.6M	2.7M	2.9M	3M	3.4M	3.8M	4.5M	5M	5.6M	6.1M
Additional Paid-In Capital	8.9B	8.9B	8.9B	9.1B	9.1B	9.2B	9.4B	9.5B	8.5B	8.8B	8.6B	10.1B	10.8B	10.9B	11.7B	12.9B	15.2B	16.8B	18.4B	19.9B
Retained Earnings	35.4B	33.5B	31.7B	29.6B	27.1B	23.8B	22.6B	20B	18.1B	16.6B	14.8B	14B	13.8B	12.6B	11.5B	10.7B	9.6B	5.5B	4.4B	4.7B
Accumulated Other Comprehensive Income/Loss	-451M	-1.1B	-1.3B	-2.5B	-178M	150M	-296M	-986M	-101M	-267.9M	-292.6M	171.9M	183.2M	299.1M	114.9M	224.6M	68.1M	-895.7M	156.1M	50.1M
Total Stockholders' Equity	43.9B	41.3B	39.3B	36.2B	36.1B	33.2B	31.7B	28.5B	26.5B	25.1B	23B	24.3B	24.8B	23.8B	23.3B	23.8B	24.9B	21.4B	23B	24.6B
Total Equity	44B	41.4B	39.4B	36.3B	36.1B	33.2B	31.7B	28.5B	26.5B	25.1B	23B	24.3B	24.8B	23.8B	23.3B	23.8B	24.9B	21.4B	23B	24.6B
Minority Interest	144M	111M	99M	87M	68M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	121.5B	116.9B	108.9B	102.8B	97.5B	86.6B	77.5B	71.6B	70.5B	65.1B	61.7B	61.7B	59.6B	59B	52.2B	50.2B	52.1B	48.4B	52.1B	51.6B
Total Investments	38.6B	37.2B	36.8B	33.3B	34B	29.8B	40.9B	22.5B	24.9B	21.4B	35.9B	21.6B	20.8B	20B	18.5B	18.4B	33.7B	15.2B	21.4B	4.9B
Total Debt	33.2B	32.7B	26.7B	25.8B	24.9B	20B	20.1B	19.2B	19.9B	15.7B	15.9B	15B	14.5B	15B	9.8B	9B	8.4B	8.8B	9B	7B
Net Debt	23.7B	24.4B	20.1B	18.4B	20B	14.3B	15.1B	15.3B	16.3B	11.7B	13.8B	12.9B	12.9B	12.5B	7.6B	7.2B	3.6B	6.7B	6.3B	4.4B
Shares Outstanding	222,238,763	222,238,763	222,238,763	222,238,763	222,238,763	222,238,763	222,238,763	222,238,763	222,238,763	222,238,763	222,238,763	222,238,763	222,238,763	222,238,763	222,238,763	222,238,763	222,238,763	222,238,763	222,238,763	222,238,763

SEC Filings

ELV - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 13, 2026	May 13, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	April 22, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 22, 2026	April 22, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	March 27, 2026	May 13, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 10, 2026	March 10, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 02, 2026	March 02, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 26, 2026	February 26, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 06, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	January 28, 2026	January 28, 2026	2026	View Filing
8-K 8-K 2025 N/A	December 10, 2025	December 10, 2025	2025	View Filing

Showing 1 to 10 of 533 filings

Related Guides

Blog Categories

Continue your ELV research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.